This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Omega Healthcare Investors (OHI) Q2 FFO Top Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 2.67% and -1.33%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare (OHI) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Though Omega Healthcare (OHI) will likely record top-line growth in Q2, elevated expenses and prevalent tenant credit headwinds are likely to keep any robust growth in check.
Is Omega Healthcare Investors (OHI) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (OHI) Outperforming Other Finance Stocks This Year?
Zacks Market Edge Highlights: Omega Healthcare Investors, Innovative Industrial Properties, Arbor Realty Trust, GEO Group and Macerich
by Zacks Equity Research
Zacks Market Edge Highlights: Omega Healthcare Investors, Innovative Industrial Properties, Arbor Realty Trust, GEO Group and Macerich
Are REITs the Hottest Stocks of 2019?
by Tracey Ryniec
REITs are slower growing companies and pay dividends. So why are so many investors clamoring to own them?
Omega Healthcare (OHI) Closes MedEquities Realty Acquisition
by Moumita Chattopadhyay
Omega Healthcare (OHI) will benefit from its focus on accretive buyouts this year. Particularly, the MedEquities Realty acquisition will help in diversification of its assets as well as operators.
Omega Healthcare Investors (OHI) Beats Q1 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 4.11% and 0.77%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare (OHI) to Post Q1 Earning: What's in Store?
by Zacks Equity Research
Though Omega Healthcare (OHI) will likely record marginal top-line growth in Q1, results may suggest prevailing legal expenses associated with operator workouts and restructurings.
Regency Centers' (REG) Q1 FFO & Revenues Beat Estimates
by Zacks Equity Research
Regency Centers' (REG) Q1 performance reflects solid leasing activity and decent rent spreads.
Federal Realty (FRT) Q1 FFO Beats Estimates, Revenues Up Y/Y
by Zacks Equity Research
Federal Realty's (FRT) Q1 performance highlights continued growth in POI and lease rollover for comparable properties.
Kimco Realty (KIM) Q1 FFO Beats Estimates on High Occupancy
by Zacks Equity Research
Kimco Realty's (KIM) Q1 results suggest decent new leasing spreads and high occupancy of the company's portfolio.
Realty Income (O) Q1 FFO and Revenues Beat Estimates
by Zacks Equity Research
Realty Income's (O) Q1 results display year-over-year growth in revenues and high occupancy levels.
Public Storage (PSA) Q1 FFO Meets Estimates, Revenues Up Y/Y
by Zacks Equity Research
Higher realized annual rent per occupied square foot aid Public Storage's (PSA) same-store performance in Q1. Additionally, the company's expansion efforts drive its performance.
Host Hotels' (HST) Q1 FFO Beats Estimates, Raises Guidance
by Zacks Equity Research
Host Hotels & Resorts' (HST) Q1 results reflect increase in average room rate, though the Marriott transformational capital program and the government shutdown affected its RevPAR performance.
A Quiet Week, A Dovish Fed Report, A Modest Rally and then...Friday
by David Borun
The yield curve inversion roils the equity markets, but is it really anything to worry about?
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $36.45 in the latest trading session, marking a +0.64% move from the prior day.
Omega Healthcare Investors (OHI) Misses Q4 FFO and Revenue Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of -3.95% and -1.58%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Omega Healthcare (OHI) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Omega Healthcare (OHI) is likely to experience marginal growth in revenues in fourth-quarter 2018. Its strategic asset-repositioning efforts and capital-deployment measures also augur well.
Omega Healthcare Investors (OHI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Omega Healthcare Investors (OHI) closed at $39.39, marking a -0.68% move from the previous day.
Zacks.com featured highlights include: El Pollo Loco, Jabil, Omega, Pandora Media and Talend
by Zacks Equity Research
Zacks.com featured highlights include: El Pollo Loco, Jabil, Omega, Pandora Media and Talend
Top Ranked Momentum Stocks to Buy for February 4th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 4th
Key Factors to Impact Digital Realty's (DLR) Q4 Earnings
by Zacks Equity Research
While Digital Realty (DLR) will likely gain from robust industry fundamentals and strategic acquisitions in Q4, aggressive pricing pressure and hike in interest rates remain drags.
Overcome Market Volatility With These 5 Low-Beta Stocks
by Zacks Equity Research
A low-risk portfolio can generate impressive returns if some specific parameters are considered.
Bear of the Day: Blackrock Capital
by David Borun
Reduced credit quality in the "middle market" continues to weigh on the Business Development Company
Omega Healthcare Investors (OHI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $40.17 in the latest trading session, marking a +1.29% move from the prior day.